{"title": "Figures and data in Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies", "author": "Nathan J Cheetham; Milla Kibble; Andrew Wong; Richard J Silverwood; Anika Knuppel; Dylan M Williams; Olivia KL Hamilton; Paul H Lee; Charis Bridger Staatz; Giorgio Di Gessa; Jingmin Zhu; Srinivasa Vittal Katikireddi; George B Ploubidis; Ellen J Thompson; Ruth CE Bowyer; Xinyuan Zhang; Golboo Abbasian; Maria Paz Garcia; Deborah Hart; Jeffrey Seow; Carl Graham; Neophytos Kouphou; Sam Acors; Michael H Malim; Ruth E Mitchell; Kate Northstone; Daniel Major-Smith; Sarah Matthews; Thomas Breeze; Michael Crawford; Lynn Molloy; Alex SF Kwong; Katie Doores; Nishi Chaturvedi; Emma L Duncan; Nicholas J Timpson; Claire J Steves", "url": "https://elifesciences.org/articles/80428/figures", "hostname": "elifesciences.org", "description": "Third SARS-CoV-2 vaccination appears to eliminate disparities in anti-Spike antibodies between those who received Pfizer-BioNTech versus Oxford/AstraZeneca for first and second vaccination, but levels remain lower in certain groups such as those on the UK 'Shielded Patient List'.", "sitename": "Elife Sciences Publications, Ltd", "date": "2023-01-24", "cleaned_text": "Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies Figures Figure 1 with 4 supplements Figure 1\u2014figure supplement 1 Figure 1\u2014figure supplement 2 Figure 1\u2014figure supplement 3 Figure 1\u2014figure supplement 4 Figure 2 Figure 3 with 1 supplement Figure 3\u2014figure supplement 1 Tables Table 1 Table 2 Table 3 Additional files - Supplementary file 1 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp1-v2.xlsx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp1-v2.xlsx) - Supplementary file 2 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp2-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp2-v2.docx) - Supplementary file 3 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp3-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp3-v2.docx) - Supplementary file 4 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp4-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp4-v2.docx) - Supplementary file 5 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp5-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp5-v2.docx) - Supplementary file 6 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp6-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp6-v2.docx) - Supplementary file 7 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp7-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp7-v2.docx) - Supplementary file 8 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp8-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp8-v2.docx) - Supplementary file 9 - [https://cdn.elifesciences.org/articles/80428/elife-80428-supp9-v2.docx](https://cdn.elifesciences.org/articles/80428/elife-80428-supp9-v2.docx) - MDAR checklist - [https://cdn.elifesciences.org/articles/80428/elife-80428-mdarchecklist1-v2.pdf](https://cdn.elifesciences.org/articles/80428/elife-80428-mdarchecklist1-v2.pdf) Download links A two-part list of links to download the article, or parts of the article, in various formats. Downloads (link to download the article as PDF) Open citations (links to open the citations from this article in various online reference manager services) Cite this article (links to download the citations from this article in formats compatible with various reference manager tools) Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two "}